{"id":184515,"date":"2025-10-02T08:00:07","date_gmt":"2025-10-02T08:00:07","guid":{"rendered":"https:\/\/www.newsbeep.com\/ca\/184515\/"},"modified":"2025-10-02T08:00:07","modified_gmt":"2025-10-02T08:00:07","slug":"trump-pfizer-deal-pushes-health-care-to-best-rally-in-5-years-agilent-technologies-nysea-biogen-nasdaqbiib","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ca\/184515\/","title":{"rendered":"Trump-Pfizer Deal Pushes Health Care To Best Rally In 5 Years &#8211; Agilent Technologies (NYSE:A), Biogen (NASDAQ:BIIB)"},"content":{"rendered":"<p class=\"block core-block\">Investors cheered a breakthrough drug pricing agreement between President Donald Trump and Pfizer Inc. (NYSE:<a class=\"ticker\" href=\"https:\/\/www.benzinga.com\/quote\/PFE\" target=\"_blank\" rel=\"nofollow noopener\">PFE<\/a>), sparking a sector-wide surge in health care stocks that delivered the biggest <a href=\"https:\/\/www.benzinga.com\/insights\/options\/25\/10\/47977423\/10-health-care-stocks-whale-activity-in-todays-session\" target=\"_blank\" rel=\"nofollow noopener\">rally in five years.<\/a><\/p>\n<p class=\"block core-block\">The Health Care Select Sector SPDR Fund (NYSE:<a class=\"ticker\" href=\"https:\/\/www.benzinga.com\/quote\/XLV\" target=\"_blank\" rel=\"nofollow noopener\">XLV<\/a>) soared over 5% across Tuesday and Wednesday, marking its best 2-day performance since November 2020 \u2014 when news of the first COVID-19 vaccine lifted markets.<\/p>\n<p class=\"block core-block\">The catalyst: a historic deal that ties U.S. drug prices to international benchmarks, with Pfizer agreeing to set a precedent.<\/p>\n<p>Health Care Sector Marks Best 2-Day Surge Since November 2020What&#8217;s in Trump&#8217;s Drug Deal With Pfizer?<\/p>\n<p class=\"block core-block\">On Tuesday, the White House announced a Most-Favored-Nation (MFN) pricing agreement with Pfizer Inc. (NYSE:<a class=\"ticker\" href=\"https:\/\/www.benzinga.com\/quote\/PFE\" target=\"_blank\" rel=\"nofollow noopener\">PFE<\/a>), aligning Medicaid drug prices in the U.S. with the lowest paid by other developed nations. <\/p>\n<p class=\"block core-block\">The administration estimates this will save state programs &#8220;many millions of dollars,&#8221; while setting the standard for other companies to follow.<\/p>\n<p class=\"block core-block\">In exchange for a three-year exemption from pharmaceutical tariffs, Pfizer Inc. agreed to a series of commitments. <\/p>\n<p class=\"block core-block\">The company will offer most-favored-nation (MFN) pricing to all U.S. state Medicaid programs, ensuring that American states pay no more than the lowest prices paid by other developed countries. <\/p>\n<p class=\"block core-block\">It will provide direct-to-patient discounts of up to 80% on select medications.<\/p>\n<p class=\"block core-block\"> Pfizer will also repatriate foreign revenue generated through favorable U.S. trade policies and invest $70 billion to expand domestic pharmaceutical manufacturing. <\/p>\n<p class=\"block core-block\">Lastly, the company will participate in &#8220;TrumpRx.gov,&#8221; a new federal direct-purchasing platform offering reduced-price medicines to American consumers.<\/p>\n<p>Tariffs Paused, But the Pressure Remains<\/p>\n<p class=\"block core-block\">The Trump administration had previously floated a 100% tariff on branded pharmaceutical products starting in October. However, officials are now using the threat of tariffs as a bargaining chip to secure similar MFN deals with other major pharmaceutical firms.<\/p>\n<p class=\"block core-block\">&#8220;We&#8217;re going to let the talks play out and finish these negotiations,&#8221; Commerce Secretary Howard Lutnick said during the Oval Office announcement. Trump added, &#8220;They&#8217;re all going to be good,&#8221; but warned that firms unwilling to negotiate would face equivalent tariffs.<\/p>\n<p>Health Stocks Rip Higher<\/p>\n<p class=\"block core-block\">Investors interpreted the Pfizer agreement as a sign that harsher pricing rules \u2014 especially for Medicare and commercial markets \u2014 could be avoided. <\/p>\n<p class=\"block core-block\">According to Goldman Sachs analyst Asad Haider, while Medicaid is a smaller revenue stream for most large-cap drugmakers, &#8220;pricing adjustments limited only to Medicaid have been interpreted as positive by some pharma companies.&#8221;<\/p>\n<p class=\"block core-block\">The following health care stocks surged more than 7% on Wednesday:<\/p>\n<p>Stock Name% ChangeThermo Fisher Scientific Inc. (NYSE:<a class=\"ticker\" href=\"https:\/\/www.benzinga.com\/quote\/TMO\" rel=\"nofollow noopener\" target=\"_blank\">TMO<\/a>)+10.01%Biogen Inc. (NASDAQ:<a class=\"ticker\" href=\"https:\/\/www.benzinga.com\/quote\/BIIB\" rel=\"nofollow noopener\" target=\"_blank\">BIIB<\/a>)+9.45%Charles River Laboratories Intl. Inc. (NYSE:<a class=\"ticker\" href=\"https:\/\/www.benzinga.com\/quote\/CRL\" rel=\"nofollow noopener\" target=\"_blank\">CRL<\/a>)+8.77%Eli Lilly and Co. (NYSE:<a class=\"ticker\" href=\"https:\/\/www.benzinga.com\/quote\/LLY\" rel=\"nofollow noopener\" target=\"_blank\">LLY<\/a>)+8.32%Agilent Technologies, Inc. (NYSE:<a class=\"ticker\" href=\"https:\/\/www.benzinga.com\/quote\/A\" rel=\"nofollow noopener\" target=\"_blank\">A<\/a>)+7.91%Bio-Techne Corporation (NASDAQ:<a class=\"ticker\" href=\"https:\/\/www.benzinga.com\/quote\/TECH\" rel=\"nofollow noopener\" target=\"_blank\">TECH<\/a>)+7.89%Moderna, Inc. (NASDAQ:<a class=\"ticker\" href=\"https:\/\/www.benzinga.com\/quote\/MRNA\" rel=\"nofollow noopener\" target=\"_blank\">MRNA<\/a>)+7.72%Merck &amp; Co., Inc. (NYSE:<a class=\"ticker\" href=\"https:\/\/www.benzinga.com\/quote\/MRK\" rel=\"nofollow noopener\" target=\"_blank\">MRK<\/a>)+7.37%IQVIA Holdings Inc. (NYSE:<a class=\"ticker\" href=\"https:\/\/www.benzinga.com\/quote\/IQV\" rel=\"nofollow noopener\" target=\"_blank\">IQV<\/a>)+7.10%Danaher Corporation (NYSE:<a class=\"ticker\" href=\"https:\/\/www.benzinga.com\/quote\/DHR\" rel=\"nofollow noopener\" target=\"_blank\">DHR<\/a>)+7.03%What&#8217;s Next?<\/p>\n<p class=\"block core-block\">President Trump signaled more deals are coming, stating that Tuesday\u2019s announcement was just the beginning. <\/p>\n<p class=\"block core-block\">With drugmakers facing a choice between steep tariffs or steep discounts, the broader sector may see further price volatility in the days and weeks ahead.<\/p>\n<p class=\"block core-block\">But for now, investors are betting that negotiated discounts under controlled terms are far better than unilateral government-imposed price caps or tax penalties.<\/p>\n<p class=\"block core-block\">Read Next:<\/p>\n<p class=\"block core-block\">Photo: Shutterstock<\/p>\n","protected":false},"excerpt":{"rendered":"Investors cheered a breakthrough drug pricing agreement between President Donald Trump and Pfizer Inc. (NYSE:PFE), sparking a sector-wide&hellip;\n","protected":false},"author":2,"featured_media":184516,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[49,48,32267,92896,32268,41005,32269,92895,32272,11669,84,392,11668,92897,92898,92899,92900,92901,41008,92902,92903,92904,92905,92906,92907,32274,32278],"class_list":{"0":"post-184515","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-healthcare","8":"tag-ca","9":"tag-canada","10":"tag-category-analyst-color","11":"tag-category-etfs","12":"tag-category-government","13":"tag-category-health-care","14":"tag-category-regulations","15":"tag-category-sector-etfs","16":"tag-category-top-stories","17":"tag-cms-wordpress","18":"tag-health","19":"tag-healthcare","20":"tag-pageisbzpro-bz","21":"tag-symbol-a","22":"tag-symbol-biib","23":"tag-symbol-crl","24":"tag-symbol-dhr","25":"tag-symbol-iqv","26":"tag-symbol-lly","27":"tag-symbol-mrk","28":"tag-symbol-mrna","29":"tag-symbol-pfe","30":"tag-symbol-tech","31":"tag-symbol-tmo","32":"tag-symbol-xlv","33":"tag-tag-donald-trump","34":"tag-tag-stories-that-matter"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/184515","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/comments?post=184515"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/184515\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media\/184516"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media?parent=184515"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/categories?post=184515"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/tags?post=184515"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}